Research | Microbiota I-Center

Our research creates notable, continuous benefits for the economy and society in Hong Kong, the Greater Bay Area, China, and worldwide science.

INFLAMMATORY
BOWEL DISEASE

Investigating the role of gut microbiome in the development and progression of inflammatory bowel diseases such as Crohn's disease and ulcerative colitis.

MENTAL HEALTH

Exploring strong connection between the gut microbiome and mental health. The gut-brain axis plays a vital role in mood regulation and overall well-being.

ANTI-AGING

Creating a "Gut Microbiome Clock" to monitor infant gut health, linking early microbiome changes to lifelong wellness and aging.

HEALTHY MICROBIOME

IN EARLY LIFE

Investigating the impact of gut microbiome on infant health and development during the early stages of life.

FMT & DEVELOPMENT
OF MICROBIAL

Studying the efficacy and safety of fecal microbiota transplantation as a therapeutic option for various gastrointestinal conditions.

COVID-19

Examining the potential link between gut microbiome and COVID-19, exploring its impact on disease severity and recovery.

INFLAMMATORY

BOWEL DISEASE 2.0

Development of ddPCR-based microbial markers for IBD diagnosis and monitoring, emphasizing gut microbiota's crucial role in management.

AUTISM SPECTRUM
DISORDER 2.0

Autism Spectrum Disorder ASD - Gut Brain Axis

Development and Validation of Fecal Microbiome-based Biomarkers for Autism Spectrum Disorder (ASD) Diagnosis," aims to revolutionize early ASD detection using gut microbiome markers, potentially transforming diagnostic methods and improving intervention timelines.

ANTI-INFLAMMATION

Developing live biotherapeutic products from gut microbiota strains to treat IBD, focusing on safety and efficacy in trials.

COGNITIVE
IMPAIRMENT

Exploring the relationship between gut microbiome and obesity, diabetes, and metabolic disorders.

OBESITY & METABOLIC
DISEASE

Exploring the relationship between gut microbiome and obesity, diabetes, and metabolic disorders.